Analysis of risk factors affecting coagulopathy after donor hepatectomy in a newly established liver transplant center

Abstract

Objective: As might be expected, living donor liver surgery is associated with serious morbidity and mortality risks. Coagulopathy after donor hepatectomy is an important risk factor affecting morbidity. In this study, risk factors affecting the development of coagulopathy after donor hepatectomy was evaluated in a newly-established liver transplant center. Material and Methods:A retrospective evaluation of 46 liver donors to whom hepatectomy was applied in Medipol Universty of School of Medicine Department of Organ Transplantation between April 2014 and July 2015 was made. Coagulopathy was defined as prothrombin time ≥15 sec. or platelet count <80000/mm 3 on postoperative day 3. Donors were separated into 2 groups as those with (n=24) and without (n=22) coagulopathy. Preoperative, intraoperative and postoperative factors acting on coagulopathy were analyzed. Results:In the intergroup analysis, it was seen that remnant liver volume, remnant liver volume % and remnant liver volume to body weight ratio were factors associated with coagulopathy. The cut-off values for these 3 parameters were calculated as 773.5cm 3 , 40.5% and 0.915 cm 3 /kg, respectively. Only remnant liver volume % was determined as a risk factor for coagulopathy after donor hepatectomy on multiple logistic regression analysis. Conclusion:The results of this study showed that the most important risk factors affecting coagulopathy after donor hepatectomy were the parameters associated with remnant liver volume.

Protective effects of St. John’s wort in the hepatic ischemia/reperfusion injury in rats

“…A hepatic I/R injury may occur in most of clinical practices including transplantation of organs, hepatectomy, trauma, and vascular diseases (20,21). Various factors contribute to the hepatic I/R injury, namely the Kupffer cell activation, oxidative stress, and upregulation of proinflammatory cytokine signaling.…”

Protective effects of spironolactone against hepatic ischemia/reperfusion injury in rats

“…Ischemia/reperfusion injury takes place in various clinical settings such as hepatic trauma, hemorrhagic shock, resection of large intrahepatic tumors, and liver transplantation (1,2). The pathophysiology of hepatic ischemia reperfusion injury involves many mechanisms.…”